Diagnostics Revolutions

Diagnostics Revolutions
  • Pininvest Analysis

By highlighting well respected companies providing systems for in-vitro diagnostics, including gene sequencing machines, and related services, we focus on advanced medical equipment used in clinical applications, in laboratories and in research.

The fastest growing areas, gene analysis techniques and splicing applied to fields of human identity testing, oncology research, infectious disease research, pharmacogenomics, and inherited disease boost research and product innovation in molecular biology (identifying potential drug targets), microbiology (defining how organisms evolve), medicine (tracking genetic diseases) and plant sciences

The breath of the applications with potential breakthrough in areas as diverse as healthcare, agriculture or environmental protection has opened vast opportunities for start-up companies applying the new technologies… but major uncertainties about commercial break-through leaves the potential investor exposed to extreme risk situations

To service the diagnostics market (evaluated at $ 60 billion and expected to continue to grow by 4% during the coming 5 years), manufacturers of the advanced medical equipment are placed on a strong footing

Diagnostics Revolutions • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Momentum Vol. Risk Contrib. MDD
 
Accelerate Diagnostics AXDX NASDAQ Health Care Lab Analytical Instruments USD 9.50 535 M -28.4% Weak Down 107%   5% -61%
Agilent Technologies A NYSE Health Care Medical Laboratories & Research USD 119.30 37 B 42.3% Neutral 36%   3% -25%
Bio-Rad Laboratories BIO NYSE Health Care Lab Analytical Instruments USD 566.87 17 B 47.3% Neutral 42%   3% -20%
Bio-Techne TECH NASDAQ Health Care Diagnostics USD 361.24 14 B 83.2% Neutral 41%   3% -18%
Bruker Corporation BRKR NASDAQ Health Care Lab Analytical Instruments USD 61.18 9.4 B 30.8% Weak Up 50%   4% -33%
Cancer Genetics CGIX NASDAQ Health Care Diagnostics USD 5.92 14 M 52.6% Strong Up 162%   5% -65%
Danaher DHR NYSE Conglomerates Industrial Conglomerates USD 219.68 156 B 41.3% Neutral 34%   3% -22%
Exact Sciences EXAS NASDAQ Health Care Diagnostics USD 126.57 19 B 68.8% Neutral 75%   5% -49%
Guardant Health GH NASDAQ Health Care Diagnostics USD 143.70 14 B 72.7% Neutral 59%   4% -20%
HTG Molecular Diagnostics HTGM NASDAQ Health Care Medical Devices USD 6.34 30 M -18.7% Weak Down 89%   3% -67%
Illumina ILMN NASDAQ Health Care Gene Editing - Cell Therapies USD 416.41 61 B 47.6% Neutral 48%   3% -33%
Laboratory Corporation Of America LH NYSE Health Care Diagnostics USD 239.92 23 B 25.5% Strong Up 52%   4% -45%
Lantheus Holdings LNTH NASDAQ Health Care Medical Consumables & Intermediates USD 18.45 1.2 B 17.4% Strong Up 64%   4% -42%
NanoString Technologies NSTG NASDAQ Health Care Diagnostics USD 68.88 2.6 B 101.7% Neutral 86%   7% -56%
NeoGenomics NEO NASDAQ Health Care Gene Editing - Cell Therapies USD 48.43 5.3 B 55.0% Neutral 61%   5% -19%
OPKO Health OPK NASDAQ Health Care Diagnostics USD 4.32 2.9 B 160.2% Weak Down 105%   6% -50%
Pacific Biosciences of California PACB NASDAQ Health Care Medical Technology USD 30.97 4.8 B 702.2% Weak Down 92%   7% -40%
PerkinElmer PKI NYSE Health Care Medical Laboratories & Research USD 126.38 14 B 42.1% Weak Down 40%   3% -21%
Quest Diagnostics Inc. DGX NYSE Health Care Diagnostics USD 116.88 16 B 3.2% Weak Down 42%   3% -37%
Quidel QDEL NASDAQ Health Care Diagnostics USD 151.60 6.4 B 83.4% Sharp Down 91%   4% -50%
Sonic Healthcare SKHHY OTC Health Care Diagnostics USD 24.85 - 30.2% Neutral 47%   3% -36%
Thermo Fisher Scientific TMO NYSE Health Care Lab Analytical Instruments USD 450.96 178 B 38.3% Weak Down 37%   3% -17%
Veracyte VCYT NASDAQ Health Care Gene Editing - Cell Therapies USD 55.38 2.8 B 119.2% Weak Down 79%   6% -32%
Waters WAT NYSE Health Care Lab Analytical Instruments USD 265.78 16 B 27.5% Neutral 40%   3% -22%